Department of Urology, Hospital Universitario Fundación Alcorcón, c\Budapest no. 1, 28922, Alcorcón, Madrid, Spain.
Department of Urology, Hospital Universitario 12 de Octubre, Madrid, Spain.
World J Urol. 2020 Dec;38(12):3121-3129. doi: 10.1007/s00345-020-03132-z. Epub 2020 Mar 5.
To investigate the effect of an Enhanced Recovery After Surgery (ERAS) program on complications and length of stay (LOS) after radical cystectomy (RC) and to assess if the number and type of components of ERAS play a key role on the decrease of surgical morbidity.
We analyzed the data of 277 patients prospectively recruited in 11 hospitals undergoing RC initially managed according to local practice (Group I) and later within an ERAS program (Group II). Two main outcomes were defined: 90-day complications rate and LOS. As secondary variables we studied 90-day mortality, 30-day readmission and transfusion rate.
Patients in Group II had a higher use of ERAS measures (98.6%) than those in Group I (78.2%) (p < 0.05). Patients in Groups I and II experienced similar complications (70.5% vs. 66%, p = 0.42). LOS was not different between Groups I and II (12.5 and 14 days, respectively, p = 0.59). The risk of having any complication decreases for patients having more than 15 ERAS measures adopted [RR = 0.815; 95% confidence interval (CI) 0.667-0.996; p = 0.045]. Avoidance of transfusion and nasogastric tube, prevention of ileus, early ambulation and a fast uptake of a regular diet are independently associated with the absence of complications.
Complications and LOS after RC were not modified by the introduction of an ERAS program. We hypothesize that at least 15 measures should be applied to maximize the benefit of ERAS.
研究加速康复外科(ERAS)方案对根治性膀胱切除术(RC)后并发症和住院时间(LOS)的影响,并评估 ERAS 方案中各组成部分的数量和类型是否对降低手术发病率起着关键作用。
我们前瞻性分析了 11 家医院的 277 例患者的数据,这些患者最初根据当地实践(I 组)接受 RC 治疗,随后纳入 ERAS 方案(II 组)。定义了两个主要结果:90 天并发症发生率和 LOS。作为次要变量,我们研究了 90 天死亡率、30 天再入院率和输血率。
与 I 组(78.2%)相比,II 组患者 ERAS 措施的使用率(98.6%)更高(p<0.05)。I 组和 II 组患者的并发症发生率相似(70.5%比 66%,p=0.42)。I 组和 II 组之间的 LOS 无差异(分别为 12.5 天和 14 天,p=0.59)。采用超过 15 项 ERAS 措施的患者发生任何并发症的风险降低[RR=0.815;95%置信区间(CI)0.667-0.996;p=0.045]。避免输血和鼻胃管、预防肠梗阻、早期活动和快速接受常规饮食与无并发症独立相关。
RC 后并发症和 LOS 未因 ERAS 方案的引入而改变。我们假设至少应采用 15 项措施以最大限度地发挥 ERAS 的益处。